Introduction
Accurate hormone testing is the foundation of root cause hormonal medicine. Yet the choice of testing modality — serum, saliva, or urine — profoundly affects what information is captured, what is missed, and how results should be interpreted. Each method measures different hormone fractions, reflects different physiological compartments, and has distinct clinical strengths and limitations.
This guide provides a mechanistic comparison of the three major hormone testing modalities, with particular focus on the DUTCH (Dried Urine Test for Comprehensive Hormones) panel — currently the most comprehensive single-test assessment of hormonal status available in clinical practice.
What Are We Actually Measuring?
Before comparing modalities, it is essential to understand the different hormone fractions that can be measured:
- Total hormone: the sum of bound and free hormone in circulation
- Free hormone: the biologically active fraction not bound to carrier proteins (SHBG, albumin, CBG); typically 1–3% of total for sex hormones
- Metabolites: downstream breakdown products of hormone metabolism; reflect how the body is processing and clearing hormones
- Diurnal patterns: how hormone levels fluctuate across the day (critical for cortisol, relevant for testosterone)
Different testing modalities capture different combinations of these fractions.
Serum Testing
What It Measures
Serum (blood) testing measures total hormone concentration in plasma at a single point in time. Most standard panels report total hormone levels; free hormone levels can be calculated (less accurate) or directly measured (more accurate but less commonly ordered).
Strengths
- Gold standard for many hormones: TSH, T4, T3, LH, FSH, ACTH, IGF-1, insulin, and most peptide hormones are best measured in serum
- Widely available and insurance-covered
- Established reference ranges with decades of clinical validation
- Required for diagnosis of primary endocrine conditions (hypothyroidism, hypogonadism, adrenal insufficiency)
Limitations
- Single time point: misses diurnal variation; a single morning cortisol captures only one moment of a dynamic curve
- Total hormone only: standard panels do not reflect bioavailable (free) hormone; a patient with high SHBG may have normal total testosterone but very low free testosterone
- No metabolite data: serum cannot reveal how hormones are being metabolized — critical for estrogen dominance, detoxification capacity, and cancer risk assessment
- Venipuncture stress: the act of blood draw can acutely elevate cortisol, confounding results
Best Used For
Thyroid panel (TSH, free T4, free T3, reverse T3), LH/FSH, ACTH stimulation testing, IGF-1, fasting insulin, SHBG, and initial hormonal screening.
Salivary Testing
What It Measures
Saliva testing measures free (unbound) hormone that has diffused from blood into saliva. Because only free hormone crosses into saliva, salivary levels reflect bioavailable hormone — the fraction that actually enters cells and exerts biological effects.
Strengths
- Free hormone measurement: directly reflects bioavailable hormone without calculation
- Diurnal sampling: non-invasive collection allows multiple samples across the day, making it ideal for mapping the cortisol awakening response (CAR) and diurnal cortisol curve
- No venipuncture stress artifact
- Convenient home collection
Limitations
- No metabolite data: like serum, saliva cannot reveal downstream hormone metabolism
- Contamination sensitivity: blood in saliva (from gum disease, brushing), food residue, and topical hormone application near the mouth can significantly skew results
- Topical hormone interference: patients using topical (transdermal) estrogen or testosterone creams often show artificially elevated salivary levels that do not reflect systemic exposure
- Limited reference range validation compared to serum
Best Used For
Diurnal cortisol mapping (4-point or 5-point salivary cortisol), cortisol awakening response, and free sex hormone assessment in patients not using topical hormones.
Urine Testing (DUTCH)
What It Measures
Urine testing measures hormone metabolites — the breakdown products produced as the liver, gut, and peripheral tissues process hormones. The DUTCH test (Dried Urine Test for Comprehensive Hormones), developed by Precision Analytical, uses dried urine collected on filter paper at multiple time points across the day and evening.
DUTCH measures:
- Free cortisol and cortisone (active and inactive cortisol)
- Cortisol metabolites (THF, THE, allo-THF) — reflecting total cortisol production and clearance rate
- Cortisol Awakening Response (CAR) via waking samples
- DHEA and DHEA-S metabolites
- Estrogen metabolites: estrone (E1), estradiol (E2), estriol (E3), and critically, the downstream metabolites 2-OH, 4-OH, and 16-OH estrone — which reflect estrogen detoxification pathways and cancer risk
- Progesterone metabolites (pregnanediol)
- Testosterone and testosterone metabolites (androsterone, etiocholanolone)
- Melatonin (6-OHMS)
- Organic acids (B12, B6, glutathione, dopamine/norepinephrine markers) in the DUTCH Complete panel
Strengths
- Metabolite mapping: the defining advantage of DUTCH — reveals not just hormone levels but how hormones are being processed. Estrogen metabolism pathways (2-OH vs. 4-OH vs. 16-OH) are critical for breast cancer risk assessment and cannot be measured by serum or saliva.
- Comprehensive HPA assessment: combines free cortisol, cortisol metabolites (total production), and CAR in a single test — the most complete picture of HPA axis function available
- Diurnal pattern: multiple collection time points capture the cortisol curve without venipuncture stress
- Unaffected by topical hormone application: unlike saliva, urine metabolites reflect systemic hormone exposure regardless of application route
- Convenient home collection
Limitations
- Does not measure peptide hormones: TSH, LH, FSH, ACTH, insulin — these must still be measured in serum
- Metabolite levels reflect production AND clearance: a patient with rapid hepatic clearance may show low metabolites despite normal production; interpretation requires clinical context
- Not insurance-covered in most cases; out-of-pocket cost typically $300–$500
- Requires practitioner interpretation: the complexity of the panel makes self-interpretation unreliable
- Kidney function dependency: impaired renal clearance can affect metabolite concentrations
Best Used For
Comprehensive hormonal assessment including HPA axis mapping, estrogen metabolism and detoxification pathway analysis, sex hormone status with metabolite context, and monitoring hormone replacement therapy (particularly oral or transdermal estrogen and progesterone).
The Estrogen Metabolism Pathways: Why DUTCH Changes the Clinical Picture
One of the most clinically significant advantages of urine metabolite testing is the ability to map estrogen detoxification pathways. Estradiol is metabolized in the liver via three competing pathways:
- 2-OH pathway (protective): produces 2-hydroxyestrone, a weak estrogen with anti-proliferative properties. Upregulated by cruciferous vegetables (DIM, I3C), exercise, and adequate methylation capacity.
- 4-OH pathway (genotoxic): produces 4-hydroxyestrone, which can form DNA adducts and is associated with increased breast and endometrial cancer risk. Elevated by CYP1B1 polymorphisms and toxin exposure.
- 16-OH pathway (proliferative): produces 16-alpha-hydroxyestrone, a potent estrogen with proliferative effects. Elevated in obesity, hypothyroidism, and pesticide exposure.
The 2:16 ratio and 2:4 ratio provide actionable risk stratification that serum estradiol alone cannot offer. This information directly guides interventions: DIM supplementation, methylation support (methylfolate, B12), and detoxification protocols.
Comparative Summary
| Feature | Serum | Saliva | DUTCH (Urine) |
|---|---|---|---|
| Free hormone | Calculated/direct | ✅ Direct | Metabolite-based |
| Total hormone | ✅ Yes | No | Via metabolites |
| Hormone metabolites | No | No | ✅ Yes |
| Diurnal cortisol | Limited | ✅ Yes | ✅ Yes (+ CAR) |
| Estrogen pathways | No | No | ✅ Yes |
| Peptide hormones | ✅ Yes | No | No |
| Topical hormone accuracy | ✅ Yes | ⚠️ Inflated | ✅ Yes |
| Insurance coverage | ✅ Usually | Varies | ❌ Rarely |
| Cost | Low | Moderate | $300–$500 |
Clinical Protocol: Which Test When?
- Initial hormonal screening: serum panel (TSH, free T4, free T3, LH, FSH, total/free testosterone, SHBG, DHEA-S, fasting insulin, IGF-1)
- HPA axis assessment: DUTCH Complete or 4-point salivary cortisol
- Estrogen dominance workup: DUTCH (essential for metabolite pathway mapping)
- Monitoring HRT: DUTCH for oral/transdermal estrogen and progesterone; serum for pellet or injectable testosterone
- Comprehensive hormonal root cause workup: serum + DUTCH Complete
Conclusion
No single testing modality captures the full hormonal picture. Serum remains essential for peptide hormones and initial screening. Saliva excels for diurnal cortisol mapping in patients not using topical hormones. DUTCH provides the most comprehensive assessment of steroid hormone status, HPA axis function, and — uniquely — the metabolite pathways that determine how hormones are processed and cleared.
A root cause approach to hormonal health requires choosing the right test for the right clinical question — and understanding that the number on a lab report is only as meaningful as the context in which it is interpreted.
0 comments